There is scarce information from the relationship of these proteins and treatments, but it recently has been demonstrated in an allergic asthma rat model the role of AIT inhibiting the HMGB1/TLR4/NF-κB signaling, in agreement with our data [68]. The gene discussed is NFKB1; the disease is allergic asthma.